References
- Akutsu, T., & Halldórsson, M. M. (2000). On the approximation of largest common subtrees and largest common point sets. Theoretical Computer Science, 233(1–2), 33–50. https://doi.org/https://doi.org/10.1016/S0304-3975(97)00278-8
- Baell, J. B., Ferrins, L., Falk, H., & Nikolakopoulos, G. (2013). PAINS: Relevance to tool compound discovery and fragment-based screening. Australian Journal of Chemistry, 66(12), 1483–1494. https://doi.org/https://doi.org/10.1071/CH13551
- Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics (Oxford, England), 27(3), 343–350. https://doi.org/https://doi.org/10.1093/bioinformatics/btq662
- Bhattacharya, D., Nowotny, J., Cao, R., & Cheng, J. (2016). 3Drefine: An interactive web server for efficient protein structure refinement. Nucleic Acids Research, 44(W1), W406–W409. https://doi.org/https://doi.org/10.1093/nar/gkw336
- Biasini, M., Bienert, S., Waterhouse, A., Arnold, K., Studer, G., Schmidt, T., Kiefer, F., Gallo Cassarino, T., Bertoni, M., Bordoli, L., & Schwede, T. (2014). SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Research, 42(Web Server issue), W252–W258. https://doi.org/https://doi.org/10.1093/nar/gku340
- Brenk, R., Schipani, A., James, D., Krasowski, A., Gilbert, I. H., Frearson, J., & Wyatt, P. G. (2008). Lessons learnt from assembling screening libraries for drug discovery for neglected diseases. ChemMedChem, 3(3), 435–444. https://doi.org/https://doi.org/10.1002/cmdc.200700139
- Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009). BLAST+: Architecture and applications. BMC Bioinformatics, 10, 421. https://doi.org/https://doi.org/10.1186/1471-2105-10-421
- Cereto-Massagué, A., Ojeda, M. J., Valls, C., Mulero, M., Garcia-Vallvé, S., & Pujadas, G. (2015). Molecular fingerprint similarity search in virtual screening. Methods (San Diego, California), 71, 58–63. https://doi.org/https://doi.org/10.1016/j.ymeth.2014.08.005
- Clark, D. E. (2008). What has virtual screening ever done for drug discovery? Expert Opinion on Drug Discovery, 3(8), 841–851. https://doi.org/https://doi.org/10.1517/17460441.3.8.841
- Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science : a Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/https://doi.org/10.1002/pro.5560020916
- Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/https://doi.org/10.1038/srep42717
- Dallakyan, S., & Olson, A. J. (2015). Small-molecule library screening by docking with PyRx. Methods in Molecular Biology, 1263, 243–250. https://doi.org/https://doi.org/10.1007/978-1-4939-2269-7_19
- DeLano, W. (2002). The PyMOL molecular graphics system. DeLano Scientific.
- Egan, W. J. (2010). Predicting ADME properties in drug discovery. In K. M. Merz, D. Ringe, & C.H. Reynolds (Eds.), Drug Design: Structure-and Ligand-Based Approaches, (pp. 165–177). New York, USA: Cambridge University Press.
- Elfiky, A., & Ibrahim, N. S. (2020). Anti-SARS and anti-HCV drugs repurposing against the Papain-like protease of the newly emerged coronavirus (2019-nCoV). Preprint from Research Square, PPR124220. https://doi.org/10.21203/rs.2.23280/v1.
- Ghose, A. K., Herbertz, T., Hudkins, R. L., Dorsey, B. D., & Mallamo, J. P. (2012). Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery. ACS Chemical Neuroscience, 3(1), 50–68. https://doi.org/https://doi.org/10.1021/cn200100h
- Gierer, S., Bertram, S., Kaup, F., Wrensch, F., Heurich, A., Krämer-Kühl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., Dittmer, U., von Hahn, T., Simmons, G., Hofmann, H., & Pöhlmann, S. (2013). The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of Virology, 87(10), 5502–5511. https://doi.org/https://doi.org/10.1128/JVI.00128-13
- Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., Niemeyer, D., Schneider, H., Drosten, C., & Pöhlmann, S. (2011). Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology, 85(9), 4122–4134. https://doi.org/https://doi.org/10.1128/JVI.02232-10
- Gns, H. S., Gr, S., Murahari, M., & Krishnamurthy, M. (2019). An update on drug repurposing: Re-written saga of the drug's fate. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 110, 700–716. https://doi.org/https://doi.org/10.1016/j.biopha.2018.11.127
- Güner, O. F. (2000). Pharmacophore perception, development, and use in drug design (Vol. 2). Internat'l University Line.
- Han, Y., & Král, P. (2020). Computational design of ACE2-based peptide inhibitors of SARS-CoV-2. ACS Nano, 14(4), 5143–5147. https://doi.org/https://doi.org/10.1021/acsnano.0c02857
- Heo, L., Park, H., & Seok, C. (2013). GalaxyRefine: Protein structure refinement driven by side-chain repacking. Nucleic Acids Research, 41(Web Server issue), W384–388. https://doi.org/https://doi.org/10.1093/nar/gkt458
- Heurich, A., Hofmann-Winkler, H., Gierer, S., Liepold, T., Jahn, O., & Pöhlmann, S. (2014). TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. Journal of Virology, 88(2), 1293–1307. https://doi.org/https://doi.org/10.1128/JVI.02202-13
- Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e278. https://doi.org/https://doi.org/10.1016/j.cell.2020.02.052
- Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
- Inbar, Y., Schneidman-Duhovny, D., Dror, O., Nussinov, R., & Wolfson, H. J. (2007, April). Deterministic pharmacophore detection via multiple flexible alignment of drug-like molecules. Paper presented at the Annual International Conference on Research in Computational Molecular Biology (RECOMB), Oakland, CA.
- Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019). TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. Journal of Virology, 93(6), e01815. https://doi.org/https://doi.org/10.1128/JVI.01815-18
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Kaeppler, U., Stiefl, N., Schiller, M., Vicik, R., Breuning, A., Schmitz, W., Rupprecht, D., Schmuck, C., Baumann, K., Ziebuhr, J., & Schirmeister, T. (2005). A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods. Journal of Medicinal Chemistry, 48(22), 6832–6842. https://doi.org/https://doi.org/10.1021/jm0501782
- Kim, T. S., Heinlein, C., Hackman, R. C., & Nelson, P. S. (2006). Phenotypic analysis of mice lacking the TMPRSS2-encoded protease. Molecular and Cellular Biology, 26(3), 965–975. https://doi.org/https://doi.org/10.1128/MCB.26.3.965-975.2006
- Koes, D. R., & Camacho, C. J. (2011). Pharmer: Efficient and exact pharmacophore search. Journal of Chemical Information and Modeling, 51(6), 1307–1314. https://doi.org/https://doi.org/10.1021/ci200097m
- Koes, D. R., & Camacho, C. J. (2012). ZINCPharmer: Pharmacophore search of the ZINC database. Nucleic Acids Research, 40(Web Server issue), W409–W414. https://doi.org/https://doi.org/10.1093/nar/gks378
- Kumar, A., & Zhang, K. Y. (2015). Hierarchical virtual screening approaches in small molecule drug discovery. Methods (San Diego, California), 71, 26–37. https://doi.org/https://doi.org/10.1016/j.ymeth.2014.07.007
- Kumari, R., Kumar, R., Consortium, O. S. D. D., & Lynn, A, Open Source Drug Discovery Consortium. (2014). g_mmpbsa-A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/https://doi.org/10.1021/ci500020m
- Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/https://doi.org/10.1107/S0021889892009944
- Laskowski, R. A., & Swindells, M. B. (2011). LigPlot+: Multiple ligand–protein interaction diagrams for drug discovery. ACS Publications.
- Lemkul, J. (2019). From proteins to perturbed Hamiltonians: A suite of tutorials for the GROMACS-2018 molecular simulation package [article v1. 0. Living Journal of Computational Molecular Science, 1(1), 5068. https://doi.org/https://doi.org/10.33011/livecoms.1.1.5068
- Li, G., & De Clercq, E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nature Reviews. Drug Discovery, 19(3), 149–150. https://doi.org/https://doi.org/10.1038/d41573-020-00016-0
- Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., Choe, H., & Farzan, M. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426(6965), 450–454. https://doi.org/https://doi.org/10.1038/nature02145
- Lipinski, C. (2002). Poor aqueous solubility—An industry wide problem in drug discovery. American Pharmaceutical Review, 5(3), 82–85.
- Maass, P., Schulz-Gasch, T., Stahl, M., & Rarey, M. (2007). Recore: A fast and versatile method for scaffold hopping based on small molecule crystal structure conformations. Journal of Chemical Information and Modeling, 47(2), 390–399. https://doi.org/https://doi.org/10.1021/ci060094h
- Marchler-Bauer, A., Bo, Y., Han, L., He, J., Lanczycki, C. J., Lu, S., Chitsaz, F., Derbyshire, M. K., Geer, R. C., Gonzales, N. R., Gwadz, M., Hurwitz, D. I., Lu, F., Marchler, G. H., Song, J. S., Thanki, N., Wang, Z., Yamashita, R. A., Zhang, D., … Bryant, S. H. (2017). CDD/SPARCLE: Functional classification of proteins via subfamily domain architectures. Nucleic Acids Research, 45(D1), D200–D203. https://doi.org/https://doi.org/10.1093/nar/gkw1129
- Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010). Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Journal of Virology, 84(24), 12658–12664. https://doi.org/https://doi.org/10.1128/JVI.01542-10
- Muegge, I. (2002). Pharmacophore features of potential drugs. Chemistry - A European Journal, 8(9), 1976–1981. https://doi.org/https://doi.org/10.1002/1521-3765(20020503)8:9<1976::AID-CHEM1976>3.0.CO;2-K
- Niu, C., Yin, J., Zhang, J., Vederas, J. C., & James, M. N. (2008). Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. Bioorganic & Medicinal Chemistry, 16(1), 293–302. https://doi.org/https://doi.org/10.1016/j.bmc.2007.09.034
- O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics, 3(1), 33. https://doi.org/https://doi.org/10.1186/1758-2946-3-33
- Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., Hromas, R., Hudson, L., Mackenzie, D. A., Muller, C. Y., Reed, J. C., Simons, P. C., Smagley, Y., Strouse, J., Surviladze, Z., … Sklar, L. A. (2011). Drug repurposing from an academic perspective. Drug Discovery Today Therapeutic Strategies, 8(3–4), 61–69. https://doi.org/https://doi.org/10.1016/j.ddstr.2011.10.002
- OriginLab. (2018). Origin, (version 2018)[computer software]. OriginLab Corporation Northampton.
- Pandey, B., Grover, S., Kaur, J., & Grover, A. (2019). Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis. Scientific Reports, 9(1), 1–15. https://doi.org/https://doi.org/10.1038/s41598-019-48940-5
- Pollastri, M. P. (2010). Overview on the rule of five. Current Protocols in Pharmacology, 49(1), 12–11. https://doi.org/https://doi.org/10.1002/0471141755.ph0912s49
- Rao, K. N., Anita, R. C., Sangeetha, R., Anirudha, L., & Subramnay, H. (2016). Crystal structure of serine protease hepsin in complex with inhibitor. To be published. RCSB PDB. Deposited: 2015-07-06. Released: 2016-07-06. https://doi.org/10.2210/pdb5CE1/pdb.
- Remmert, M., Biegert, A., Hauser, A., & Söding, J. (2011). HHblits: Lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nature Methods, 9(2), 173–175. https://doi.org/https://doi.org/10.1038/nmeth.1818
- Robson, B. (2020). COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance. Computers in Biology and Medicine, 121, 103749. https://doi.org/https://doi.org/10.1016/j.compbiomed.2020.103749
- Salentin, S., Schreiber, S., Haupt, V. J., Adasme, M. F., & Schroeder, M. (2015). PLIP: Fully automated protein-ligand interaction profiler. Nucleic Acids Research, 43(W1), W443–W447. https://doi.org/https://doi.org/10.1093/nar/gkv315
- Sánchez-Linares, I., Pérez-Sánchez, H., Cecilia, J. M., & García, J. M. (2012). High-throughput parallel blind virtual screening using BINDSURF. BMC Bioinformatics, 13(Suppl 14), S13. https://doi.org/https://doi.org/10.1186/1471-2105-13-S14-S13
- Schneidman-Duhovny, D., Dror, O., Inbar, Y., Nussinov, R., & Wolfson, H. J. (2008). PharmaGist: A webserver for ligand-based pharmacophore detection. Nucleic Acids Research, 36(Web Server issue), W223–W228. https://doi.org/https://doi.org/10.1093/nar/gkn187
- Schüttelkopf, A. W., & Van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallographica Section D Biological Crystallography, 60(8), 1355–1363. https://doi.org/https://doi.org/10.1107/S0907444904011679
- Shatsky, M., Shulman-Peleg, A., Nussinov, R., & Wolfson, H. J. (2006). The multiple common point set problem and its application to molecule binding pattern detection. Journal of Computational Biology: A Journal of Computational Molecular Cell Biology, 13(2), 407–428. https://doi.org/https://doi.org/10.1089/cmb.2006.13.407
- Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., Chappell, J. D., Lu, X., Hughes, T. M., George, A. S., Hill, C. S., Montgomery, S. A., Brown, A. J., Bluemling, G. R., Natchus, M. G., … Baric, R. S. (2020). An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Science Translational Medicine, 12(541), eabb5883. https://doi.org/https://doi.org/10.1126/scitranslmed.abb5883
- Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011). A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology, 85(2), 873–882. https://doi.org/https://doi.org/10.1128/JVI.02062-10
- Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
- Turner, P. (2005). XMGRACE, Version 5.1.25. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology.
- Varma, M. V. S., Khandavilli, S., Ashokraj, Y., Jain, A., Dhanikula, A., Sood, A., Thomas, N. S., Pillai, O., Sharma, P., Gandhi, R., Agrawal, S., Nair, V., & Panchagnula, R. (2004). Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research. Current Drug Metabolism, 5(5), 375–388. https://doi.org/https://doi.org/10.2174/1389200043335423
- Vedani, A., Dobler, M., Hu, Z., & Smieško, M. (2015). OpenVirtualToxLab-A platform for generating and exchanging in silico toxicity data. Toxicology Letters, 232(2), 519–532. https://doi.org/https://doi.org/10.1016/j.toxlet.2014.09.004
- Verschueren, K. H., Pumpor, K., Anemüller, S., Chen, S., Mesters, J. R., & Hilgenfeld, R. (2008). A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters. Chemistry & Biology, 15(6), 597–606. https://doi.org/https://doi.org/10.1016/j.chembiol.2008.04.011
- Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. The Lancet, 395(10223), 470–473. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30185-9
- Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/https://doi.org/10.1093/nar/gky427
- World Health Organization (WHO). (2020a). Coronavirus disease 2019 (COVID-19): situation report, 76. WHO. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200405-sitrep-76-covid-19.pdf?sfvrsn=6ecf0977_4.
- World Health Organization (WHO). (2020b). Coronavirus disease 2019 (COVID-19): situation report, 106. WHO. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200505covid-19-sitrep-106.pdf?sfvrsn=47090f63_2.
- Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server issue), W407–W410. https://doi.org/https://doi.org/10.1093/nar/gkm290
- Wu, Q., Peng, Z., Zhang, Y., & Yang, J. (2018). COACH-D: Improved protein-ligand binding sites prediction with refined ligand-binding poses through molecular docking. Nucleic Acids Research, 46(W1), W438–W442. https://doi.org/https://doi.org/10.1093/nar/gky439
- Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J-i., & Matsuda, Z. (2016). Identification of nafamostat as a potent inhibitor of middle east respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrobial Agents and Chemotherapy, 60(11), 6532–6539. https://doi.org/https://doi.org/10.1128/AAC.01043-16
- Yang, J., Roy, A., & Zhang, Y. (2013a). BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions. Nucleic Acids Research, 41(Database issue), D1096–D1103. https://doi.org/https://doi.org/10.1093/nar/gks966
- Yang, J., Roy, A., & Zhang, Y. (2013b). Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment. Bioinformatics, 29(20), 2588–2595. https://doi.org/https://doi.org/10.1093/bioinformatics/btt447
- Zhexin, X. (2006). Advances in homology protein structure modeling. Current Protein & Peptide Science, 7(3), 217–227.
- Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., Chen, H.-D., Chen, J., Luo, Y., Guo, H., Jiang, R.-D., Liu, M.-Q., Chen, Y., Shen, X.-R., Wang, X., … Shi, Z.-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/https://doi.org/10.1038/s41586-020-2012-7
- Zhu, L., George, S., Schmidt, M. F., Al-Gharabli, S. I., Rademann, J., & Hilgenfeld, R. (2011). Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease. Antiviral Research, 92(2), 204–212. https://doi.org/https://doi.org/10.1016/j.antiviral.2011.08.001
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W., China Novel Coronavirus Investigating and Research Team. (2020). A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017